VIVUS Announces Date of First Quarter 2013 Financial Results and Conference Call

MOUNTAIN VIEW, Calif., May 1, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it will report financial results for the first quarter ended March 31, 2013 before the NASDAQ Market opens on Wednesday, May 8, 2013. The company will conduct a conference call and an audio webcast at 8:30am EDT the same day.

Date: May 8, 2013

Time: 8:30 AM EDT

Listen via Internet:

U.S. Toll-free: 877-359-2916

Outside U.S.: (+) 224-357-2386

A webcast replay will be available on the VIVUS website for 30 days.


VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. For more information about the company, please visit

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "estimate," "expect", "forecast," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS' Form 10-K for the year ending December 31, 2012, and periodic reports filed with the Securities and Exchange Commission.

CONTACT: VIVUS, Inc. Timothy E. Morris Chief Financial Officer Dana B. Shinbaum Investor Relations: The Trout Group Brian Korb 646-378-2923 Morrow & Co., LLC Joseph J. Mills 203-658-9423 Media Relations: GolinHarris Ashley Buford (212) 373-6045 Joele Frank, Wilkinson Brimmer Katcher Matthew Sherman | Jennifer Beugelmans | 212-235-2665 | 212-895-8692Source:VIVUS, Inc.